A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder (Q30498105)

17 October 2017

A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

17 October 2017

1 reference

1 reference

cognitive behavioral therapy

1 reference

Eric A Storch

1 reference

17 October 2017

Tanya K Murphy

1 reference

17 October 2017

Wayne K Goodman

1 reference

17 October 2017

Gary R Geffken

1 reference

17 October 2017

Adam B Lewin

1 reference

17 October 2017

Aude Henin

1 reference

17 October 2017

Jamie A Micco

1 reference

17 October 2017

Susan Sprich

1 reference

17 October 2017

Sabine Wilhelm

1 reference

17 October 2017

Michael Bengtson

1 reference

17 October 2017

Daniel A Geller

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

17 October 2017

Biological Psychiatry

1 reference

17 October 2017

1 reference

17 October 2017

1 reference

17 October 2017

1073-1076

1 reference

SSRI adverse events: how to monitor and manage

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Effects of D-cycloserine on extinction: translation from preclinical to clinical work

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Role of norepinephrine in the pathophysiology and treatment of mood disorders

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

The epidemiology of obsessive-compulsive disorder in children and adolescents.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Context, time, and memory retrieval in the interference paradigms of Pavlovian learning

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

Functional impairment in children and adolescents with obsessive-compulsive disorder

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034091

10.1016/J.BIOPSYCH.2010.07.015

26 November 2018

Identifiers

DOI

1 reference

17 October 2017

1 reference

17 October 2017

PubMed publication ID

20817153

1 reference